BullFrog AI Holdings, Inc. SEC filings BFRG
BullFrog AI Holdings, Inc. has 205 filings in SEC EDGAR's recent list, going back to Oct 22, 2020. Its latest annual report, Form 10-K, was filed on Mar 19, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 20, 2026 (listing notice). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | May 1, 2026 | — |
| DEF 14A | Proxy statement | Apr 30, 2026 | Apr 30, 2026 |
| DEF 14A | Proxy statement | Sep 26, 2025 | Sep 26, 2025 |
| PRE 14A | Preliminary proxy statement | Sep 16, 2025 | Sep 16, 2025 |
| DEF 14A | Proxy statement | Aug 8, 2025 | Aug 8, 2025 |
| DEF 14A | Proxy statement | Aug 8, 2024 | Aug 8, 2024 |
Showing 6 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BFRG (Nasdaq), BFRGW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Gaithersburg, MD
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1829247
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.